Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Information for Advertisers
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Editor Picks
    • Blogging Stroke
    • AHA/ASA Guidelines and Statements
    • ISC and Nursing Symposium Abstracts
    • Progress and Innovation Award Recipients
    • Acknowledgment of Reviewers
    • Stem Cells and Stroke
    • Stroke in Women
    • Outstanding Reviewers 2017
  • Resources
    • Online Submission/Peer Review
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • → Tips for Submission
    • → Links and Forms
    • → Revised Manuscripts
    • Costs to Authors
    • Journal Policies
    • Wolters Kluwer Author Services
    • Early Career Resources
    • Stroke CME
    • Webinar Series
    • Permissions and Rights Q&A
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Stroke

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Information for Advertisers
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Editor Picks
    • Blogging Stroke
    • AHA/ASA Guidelines and Statements
    • ISC and Nursing Symposium Abstracts
    • Progress and Innovation Award Recipients
    • Acknowledgment of Reviewers
    • Stem Cells and Stroke
    • Stroke in Women
    • Outstanding Reviewers 2017
  • Resources
    • Online Submission/Peer Review
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • → Tips for Submission
    • → Links and Forms
    • → Revised Manuscripts
    • Costs to Authors
    • Journal Policies
    • Wolters Kluwer Author Services
    • Early Career Resources
    • Stroke CME
    • Webinar Series
    • Permissions and Rights Q&A
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Original Contribution

Isolated MCA Disease in Patients Without Significant Atherosclerotic Risk Factors

A High-Resolution Magnetic Resonance Imaging Study

Sung-Ho Ahn, Jookyung Lee, Yeon-Jung Kim, Sun U. Kwon, Deokhee Lee, Seung-Chai Jung, Dong-Wha Kang, Jong S. Kim
Download PDF
https://doi.org/10.1161/STROKEAHA.114.008181
Stroke. 2015;46:697-703
Originally published January 27, 2015
Sung-Ho Ahn
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jookyung Lee
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeon-Jung Kim
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sun U. Kwon
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deokhee Lee
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung-Chai Jung
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong-Wha Kang
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jong S. Kim
From the Department of Neurology (S.-H.A., J.L., Y.-J.K., S.U.K., D.-W.K., J.S.K.) and Neuroradiology (D.L., S.-C.J.), University of Ulsan, Asan Medical Center, Seoul, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

This article has a correction. Please see:

  • Correction - September 01, 2015
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
Loading

Abstract

Background and Purpose—Diagnosis of intracranial artery atherosclerosis remains often uncertain. The high-resolution magnetic resonance imaging (HR-MRI) enables vessel wall assessment for more precise diagnoses. The aim of the present study was to investigate the etiologies of middle cerebral artery steno-occlusive disease in young adult patients with few atherosclerotic risk factors using HR-MRI.

Methods—We prospectively studied patients who visited a tertiary hospital in Seoul, Korea, and had (1) unilateral middle cerebral artery disease (≥50% stenosis or occlusion), (2) were ≤55 years old and had no or minimal (≤1) atherosclerotic risk factors. We excluded patients with a confirmed diagnosis of Moyamoya disease, vasculitis, or dissection and those having emboligenic sources. A presumptive diagnosis was made based on HR-MRI findings, and patients were categorized as HR-athero (atherosclerotic disease), HR-MMD (Moyamoya disease), HR-dissection, or HR-vasculitis.

Results—Among 95 patients analyzed, 26 (27.4%) had HR-athero who were more often male (P=0.004), smokers (P=0.018), and had focal stenosis (P=0.003) than others. As compared with the HR-athero patients, 29 HR-MMD patients were more often female (P<0.001) and more often had occlusive lesions (P=0.001) and nonfocal stenosis (P<0.001). The 22 HR-dissection patients tended to have hypertension less often, and the 13 HR-vasculitis patients were younger (P=0.004) and tended to have nonfocal stenosis.

Conclusions—In our cohort of young patients with minimal risk factors, atherosclerosis seems to be an uncommon pathology of middle cerebral artery stenosis. HR-MRI aids us to make a more reliable diagnosis.

  • atherosclerosis
  • dissection
  • middle cerebral artery
  • Moyamoya disease

Introduction

Cerebral artery atherosclerosis, a major cause of ischemic stroke, can be divided into intracranial atherosclerosis (ICAS) and extracranial atherosclerosis. ICAS is more common in Asians than in Caucasians.1 Previous studies have addressed the differences in risk factors between ICAS and extracranial atherosclerosis to provide a possible explanation for the racial difference, but the results have been inconsistent; reports that hypertension,2,3 diabetes mellitus,4 and metabolic syndrome5 are more closely associated with ICAS were not confirmed by other studies.6,7 Hence, the reason for racial or individual differences in the location of cerebral atherosclerosis remains unclear.8

One of the reasons for the inconsistent results may be an incorrect diagnosis; methods commonly used for the diagnosis of ICAS include computed tomography angiography, magnetic resonance angiography, or conventional angiography. These imaging modalities have limitations in that they can examine only the luminal stenosis without providing information regarding the vascular wall pathology. Therefore, nonatherosclerotic etiologies such as Moyamoya disease (MMD), dissection, and vasculitis may have been erroneously included in the category of ICAS, especially in young patients without significant atherosclerotic risk factors.

Currently, high-resolution magnetic resonance imaging (HR-MRI) enables us to assess the vessel wall pathology. Characterization of atherosclerotic plaques and other pathologies affecting the intracranial artery have been investigated using HR-MRI.9–14 The aim of the present study was to investigate the etiologies of unilateral middle cerebral artery (MCA) steno-occlusive disease in young adult patients with minimal atherosclerotic risk factors using HR-MRI.

Methods

Patients

We prospectively enrolled patients who visited the Asan Medical Center, Seoul, Korea, between March 2011 and December 2013 with unilateral MCA disease (≥50% stenosis or occlusion) because of presumptive MCA atherosclerosis. Included were patients who (1) were ≤55 years old and (2) had no or minimal (≤1) atherosclerotic risk factors (eg, hypertension, diabetes mellitus, dyslipidemia, and current cigarette smoking). We excluded patients whose diagnosis was made with certainty (ie, MMD associated with bilateral narrowing of the internal carotid arteries or MCAs with Moyamoya-type baseline collaterals, vasculitis associated with clear laboratory evidence, active central nervous system infection and multiple cerebral arterial narrowing, or dissection associated with the presence of a double lumen or aneurysmal formation). To exclude embolic occlusion, we excluded patients with emboligenic heart disease (eg, atrial fibrillation, mechanical prosthetic valve disease, sick sinus syndrome, dilated cardiomyopathy, left ventricular thrombus, or recent myocardial infarction) and those having significant (≥50%) stenosis of the ipsilateral internal carotid artery or common carotid artery. This study was approved by the institutional review board of our hospital, and informed consent was obtained from the individual patients.

Imaging

MR imaging was performed using the Achieva 3.0-T HR-MRI scanner (Philips Healthcare, Eindhoven, The Netherlands). Three-dimensional time-of-flight magnetic resonance angiography, T1-weighted, T2-weighted, proton density–weighted, and contrast-enhanced proton density images were obtained. The parameters of the imaging sequences were as follows: T1-weighted (repetition time/echo time, 600/12 ms; slice thickness, 1.5 mm; 512×512 matrix); T2-weighted (repetition time/echo time, 3000/80 ms; slice thickness, 1.5 mm; 512×512 matrix); and proton density (repetition time/echo time, 1000/20 ms; field of view, 200×200 mm; matrix size, 720×720 matrix; slice thickness, 1 mm; interslice gap, 0.5 mm; average, 1). Sagittal images were obtained perpendicular to the M1 segment of the relevant MCA. Post-enhanced T1-weighted enhanced image were taken using gadolinium unless contraindicated.

Imaging Analysis

The HR-MRI findings were reviewed and interpreted by consensus between a stroke neurologist (S.H. Ahn) and a neuro-radiologist (D.H. Lee), both of whom were blind to the findings of the initial MRI and clinical characteristics of the patients.

A presumptive diagnosis was made based on HR-MRI according to previous reports,15–17 that is, (1) atherosclerotic disease based on HR-MRI findings (HR-athero): an HR-MRI showing eccentric, irregular wall thickening; gadolinium enhancement of the plaque may be present reflecting plaque instability (Figure 1A and 1B); (2) MMD based on HR-MRI findings (HR-MMD): an HR-MRI showing extensive development of basal collateral vessels and concentric narrowing of the vessel lumen without plaque or eccentric wall thickening (Figure 1C and 1D); (3) dissection based on HR-MRI findings (HR-Dissection): an HR-MRI showing a dissecting flap or eccentric wall thickening associated with T1 bright wall components representing an intramural hematoma (Figure 2A and 2B); and (4) vasculitis based on HR-MRI findings (HR-Vasculitis): an HR-MRI showing smooth circumferential concentric wall thickening with diffuse gadolinium enhancement of the inflamed wall (Figure 2C and 2D). The pattern of stenosis was classified into focal (≤1/3 of M1 segment), segmental (<2/3 of M1 segment), multifocal, or total involvement.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Characteristic features of high-resolution magnetic resonance imaging (HR-MRI) in patients with presumptive atherosclerosis and Moyamoya disease (MMD). A and B, HR-Athero. 3D TOF-MRA shows focal stenosis of the right middle cerebral artery (MCA; arrow). Proton density HR-MRI reveals eccentric wall thickening (arrowheads) on the antero-basal portion of the stenotic lesion, which is considered to be a plaque. C and D, HR-MMD. 3D TOF-MRA shows focal stenosis of the right MCA (arrow). Proton density HR-MRI shows a collapsed vessel lumen (arrow) with well-developed basal collaterals (arrowheads) in sagittal (upper image) and axial (lower image) sections. MRA indicates magnetic resonance angiography.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Characteristic features of high-resolution magnetic resonance imaging (HR-MRI) in patients with dissection and vasculitis. A and B, HR-Dissection. 3D TOF-MRA shows segmental stenosis of the right middle cerebral artery (MCA; arrow). Proton density–weighted HR-MRI reveals a dissecting flap with pseudolumen formation (arrowheads) on the basal portion of the stenotic lesion. C and D, HR-Vasculitis. 3D TOF-MRA shows multifocal stenosis of the left MCA (arrow). Post-enhanced proton density-weighted HR-MRI indicates a concentric stenosis with diffuse circumferential enhancement (arrowheads). MRA indicates magnetic resonance angiography.

Clinical Assessment

Demographic features and risk factors were recorded including, hypertension (defined as receiving medication for hypertension or blood pressure >140/90 mm Hg on repeated measurements), diabetes mellitus (defined as receiving medication for diabetes mellitus, fasting blood sugar ≥126 mg/dL, or 2-hour postprandial blood sugar ≥200 mg/dL), hyperlipidemia (defined as receiving medication for hypercholesterolemia or an overnight fasting cholesterol level >200 mg/dL or low-density lipoprotein ≥130 mg/dL), and cigarette smoking (a current smoker or a patient who quit smoking <6 months prior).

Statistical Analysis

The Fisher exact test or χ2 test was performed to assess the categorical variables. Differences in continuous variables were evaluated using the Student’s t test. In addition, the comparison among 4 groups was performed by analysis of variance for continuous variables. A 2-tailed P value of <0.05 was considered statistically significant. For multiple testing, a significance level was considered as 0.008 (=0.05/6) by Bonferroni correction. Statistical analyses were conducted using SPSS for Windows (version 17.0, IBM SPSS, Chicago, IL).

Results

Patient Characteristics

A total of 95 patients (43 men) were enrolled. The mean age±SD was 41.3±9.3 years. The vascular risk factors included hypertension (n=19, 20.0%), diabetes mellitus (n=7, 7.4%), hyperlipidemia (n=33, 34.7%), cigarette smoking (n=30, 31.6%), and a family history of stroke (n=29, 30.5%).

Segregation of Patients With HR-Athero Versus Other Diseases

HR-athero was diagnosed in 26/95 (27.4%) patients, whereas 69 patients revealed findings of nonatherosclerotic diseases (HR-nonathero; Table 1). The HR-athero group was more often associated with male (18/26 [69.2%] versus 25/69 [36.2%]; P=0.004), smoking (13/26 [50.0%] versus 17/69 [24.6%]; P=0.018), and focal stenosis (17/26 [65.4%] versus 19/69 [27.5%]; P=0.003) than the HR-nonathero group.

View this table:
  • View inline
  • View popup
Table 1.

Comparison of Clinical Variables Between HR-Athero and HR-Nonathero Patients

Comparison Between HR-Athero and Subgroups of HR-Nonathero

Of the 69 HR-nonathero patients, there were 29 in the HR-MMD group, 22 in the HR-dissection group, and 18 in the HR-vasculitis group (Table 1). Compared with the HR-athero patients, the HR-MMD patients were more often female (P<0.001) and more often had occlusive lesions (P=0.001) and nonfocal stenosis (P<0.001). The HR-dissection patients tended to have hypertension less often (P=0.020). The HR-vasculitis patients were younger (P=0.004) and tended to have nonfocal stenosis (P=0.018). The comparison among the 4 groups was also presented in Table 1.

Comparison Between Cerebral Angiography and HR-MRI Findings

Of the 95 patients, 56 (11 of 26 HR-athero, 18 of 29 HR-MMD, 15 of 22 HR-dissection, and 12 of 18 HR-vasculitis) underwent additional conventional angiography. There were no significant differences in clinical characteristics between the patients who underwent cerebral angiography and those who did not, except for the age (Table I in the online-only Data Supplement). The presumptive diagnoses based on the cerebral angiography and the HR-MRI was identical in the majority of patients, but 13 cases showed a discrepancy (Table 2). Among the 18 HR-MMD patients, 4 patients had presumptive atherosclerosis or MMD by cerebral angiography caused by suspicious development of Moyamoya vessels. Among the 15 HR-dissection patients, 6 patients had presumptive atherosclerosis by cerebral angiography. Among the 12 HR-vasculitis patients, 2 had suspected MMD, whereas one had presumed atherosclerosis by conventional angiography.

View this table:
  • View inline
  • View popup
Table 2.

Patients With Discrepant Findings Between Cerebral Angiography and HR-MRI

Discussion

Using HR-MRI, we examined the vessel wall status in young adult patients with unilateral MCA disease who had minimal risk factors. HR-MRI including black-blood precontrast and postcontrast T1-weighted sequences with fat suppression image can delineate the arterial wall from the lumen and the surrounding perivascular structures,18 and postcontrast T1-weighted sequences can be used to identify the contrast enhancement of the arterial wall.12

We found that only 26 of the 95 (27.4%) patients showed HR-MRI findings compatible with atherosclerosis. Other nonatherosclerotic findings included HR-MMD (29 patients), HR-dissection (22 patients), and HR-vasculitis (18 patients). The HR-athero patients were more often male and smokers. Cigarette smoking is an important risk factor for cerebral infarction in young adults.19 The male dominance in the HR-athero group may in part be because of the different smoking prevalence between males and female. There also is a tendency for HR-athero patients to be older and more often have vascular risk factors. Therefore, the presence of risk factors, especially smoking, suggests atherosclerotic pathology even in young patients.

We found that HR-MMD is the most often encountered finding among patients without HR-athero. Although MMD is characterized by bilateral distal internal carotid artery or MCA occlusions with well-developed basal collaterals, atypical cases, such as those with unilateral steno-occlusive disease, are occasionally encountered.20 Moreover, in the early stage, patients may present with focal MCA stenosis without sufficient development of basal collaterals.21 HR-MRI may aid us in the diagnosis of MMD by revealing features, such as concentric narrowing of the vessel without wall thickening, and the fine meshwork of basal collateral vessels (Figure 1C and 2D).17 In our series, there were 4 patients with equivocal diagnosis (atherosclerosis or MMD; cases 1–4 in Table 2) who were eventually considered an MMD after an HR-MRI examination.

MMD is more prevalent in women,22 and previous reports on Asian patients have shown that ICAS is more closely associated with a female sex and younger age than extracranial atherosclerosis.23,24 Considering the high prevalence of HR-MMD among nonatherosclerotic MCA disease in our cohort, we suspect that these epidemiological results may, at least in part, be because of an erroneous inclusion of MMD in the ICAS group, especially in Asian patients. We suggest that HR-MRI is useful in the diagnosis of MMD, particularly in atypical cases.

HR-Dissection has been found to be another common finding in our cohort. Cervicocerebral artery dissection accounts for 1% to 2% of all ischemic strokes25 and is one of the major causes of stroke in young patients.26 Intracranial dissection is less frequent (12.5%–13.4%) and seems to occur in relatively younger patients than those with extracranial dissections.26 However, the frequency of intracranial dissections may have been underestimated because of diagnostic difficulties. HR-MRI may provide supporting evidence of dissection, such as a dissecting flap, mural hematoma, or thrombus (Figure 2A and 2B).27,28 In our current analysis, 6 of the HR-dissection patients (cases 5–10 in Table 2) were initially diagnosed as having presumptive atherosclerosis even after cerebral angiography (Figure 3). HR-MRI seems to be especially useful in identifying the chronic stage of dissection because in this stage many patients show nonspecific findings, such as segmental stenosis or occlusion without revealing pathognomonic findings (eg, an intimal flap, false lumen, or pseudoaneurysm).29

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Cerebral angiography and high-resolution magnetic resonance imaging (HR-MRI) analysis of a patient (case 5 in Table 2) with discrepant findings. A and B, Cerebral angiography shows focal stenosis of the left proximal M1 portion (arrow), which is initially considered to be an atherosclerotic lesion. C and D, Proton density–weighted HR-MRI reveals a focal bright signal intensity, which is consistent with an intimal hematoma secondary to arterial dissection (arrowheads). MRA indicates magnetic resonance angiography.

HR-vasculitis in our study was associated with young age and tended to have nonfocal stenotic lesions than HR-athero. Previous reports have shown that inflammatory conditions are associated with concentric, circumferential wall thickening and enhancement (Figure 2C and 2D).15,30 However, the laboratory test results supporting vasculitis (eg, lupus anticoagulant, anticardiolipin antibody, rheumatoid factor, antinuclear antibody, antids-DNA antibody, beta-2-GPI antibody, and an antithyroid antibody test), which were done in 12 of our 18 HR-vasculitis patients, were generally negative; only 2 patients showed a positive antinuclear antibody test and 1 was positive for anti-TPO antibody. This is probably related with our exclusion of typical vasculitis patients (eg, clear clinical and laboratory evidence of infection). Although our HR-vasculitis patients did not show characteristics findings suggesting other pathologies (eg, eccentric wall thickening or concentric narrowing, etc), vessel walls in patients with atherosclerosis or MMD may also be enhanced.31,32 Furthermore, vasculitis may show variable enhancement pattern of the vessel wall (eg, eccentric wall enhancement)30 or even diminishing enhancement pattern depending on the inflammatory status.33 Therefore, HR-MRI may not be highly specific for the diagnosis of vasculitis. Further studies are required to elucidate the correct pathology in patients revealing HR-MRI findings suggestive of vasculitis, despite the lack of clinical and laboratory evidence of vasculitis.

Our study had limitations. First, there was a lack of histopathologic correlations with which to compare the HR-MRI findings. With difficulty in obtaining pathological findings, identification of susceptibility gene, such as RNF213, may further consolidate the diagnosis of MMD.34 The gene tests were available only recently in our center, and we were able to identify only 3 patients who showed positivity. Further studies on MMD patients are required that used both HR-MRI and gene tests. Second, our enrolled patients were all Koreans. Because certain diseases, such as MMD, are more prevalent in Asians, the proportion of nonatherosclerotic disease in our series may not be generalizable. Despite these limitations, our data show that nonatherosclerotic intracranial MCA stenosis is prevalent in young patients with minimal risk factors who are initially considered to have presumptive ICAS with conventional magnetic resonance angiography. Contamination with these nonatherosclerotic intracranial diseases may have distorted the results of previous epidemiological studies of ICAS. More importantly, it seems that at least some patients with intracranial stenosis are erroneously diagnosed and treated. HR-MRI allows us to examine the vessel wall and aid the diagnosis of atherosclerosis versus other etiologies, including MMD, dissection, and vasculitis.

Sources of Funding

This work is supported by a grant from Ministry for Health, Welfare and Family Affairs, Republic of Korea (HI14C1985).

Disclosures

None.

Footnotes

  • The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.114.008181/-/DC1.

  • Received November 19, 2014.
  • Revision received December 26, 2014.
  • Accepted December 26, 2014.
  • © 2015 American Heart Association, Inc.

References

  1. 1.↵
    1. Bang OY
    . Intracranial atherosclerosis: current understanding and perspectives. J Stroke. 2014;16:27–35. doi: 10.5853/jos.2014.16.1.27.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Caplan LR,
    2. Gorelick PB,
    3. Hier DB
    . Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648–655.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Chaturvedi S,
    2. Turan TN,
    3. Lynn MJ,
    4. Kasner SE,
    5. Romano J,
    6. Cotsonis G,
    7. et al
    ; WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063–2068. doi: 10.1212/01.wnl.0000279338.18776.26.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Rincon F,
    2. Sacco RL,
    3. Kranwinkel G,
    4. Xu Q,
    5. Paik MC,
    6. Boden-Albala B,
    7. et al
    . Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis. 2009;28:65–71. doi: 10.1159/000219299.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Bang OY,
    2. Kim JW,
    3. Lee JH,
    4. Lee MA,
    5. Lee PH,
    6. Joo IS,
    7. et al
    . Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology. 2005;65:296–298. doi: 10.1212/01.wnl.0000168862.09764.9f.
    OpenUrlCrossRef
  6. 6.↵
    1. Wityk RJ,
    2. Lehman D,
    3. Klag M,
    4. Coresh J,
    5. Ahn H,
    6. Litt B
    . Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27:1974–1980.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Kim YD,
    2. Choi HY,
    3. Jung YH,
    4. Nam CM,
    5. Yang JH,
    6. Cho HJ,
    7. et al
    . Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis. Neuroepidemiology. 2009;32:201–207. doi: 10.1159/000195690.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kim JS,
    2. Bonovich D
    . Research on intracranial atherosclerosis from the East and west: why are the results different? J Stroke. 2014;16:105–113. doi: 10.5853/jos.2014.16.3.105.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Klein IF,
    2. Lavallée PC,
    3. Touboul PJ,
    4. Schouman-Claeys E,
    5. Amarenco P
    . In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology. 2006;67:327–329. doi: 10.1212/01.wnl.0000225074.47396.71.
    OpenUrlCrossRef
  10. 10.↵
    1. Ryu CW,
    2. Jahng GH,
    3. Kim EJ,
    4. Choi WS,
    5. Yang DM
    . High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis. 2009;27:433–442. doi: 10.1159/000209238.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Xu WH,
    2. Li ML,
    3. Gao S,
    4. Ni J,
    5. Zhou LX,
    6. Yao M,
    7. et al
    . In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis. 2010;212:507–511. doi: 10.1016/j.atherosclerosis.2010.06.035.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Vergouwen MD,
    2. Silver FL,
    3. Mandell DM,
    4. Mikulis DJ,
    5. Swartz RH
    . Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol. 2011;68:338–342. doi: 10.1001/archneurol.2011.20.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Degnan AJ,
    2. Gallagher G,
    3. Teng Z,
    4. Lu J,
    5. Liu Q,
    6. Gillard JH
    . MR angiography and imaging for the evaluation of middle cerebral artery atherosclerotic disease. AJNR Am J Neuroradiol. 2012;33:1427–1435. doi: 10.3174/ajnr.A2697.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Kim SM,
    2. Ryu CW,
    3. Jahng GH,
    4. Kim EJ,
    5. Choi WS
    . Two different morphologies of chronic unilateral middle cerebral artery occlusion: evaluation using high-resolution MRI. J Neuroimaging. 2014;24:460–466. doi: 10.1111/jon.12009.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Swartz RH,
    2. Bhuta SS,
    3. Farb RI,
    4. Agid R,
    5. Willinsky RA,
    6. Terbrugge KG,
    7. et al
    . Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology. 2009;72:627–634. doi: 10.1212/01.wnl.0000342470.69739.b3.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Li ML,
    2. Xu WH,
    3. Song L,
    4. Feng F,
    5. You H,
    6. Ni J,
    7. et al
    . Atherosclerosis of middle cerebral artery: evaluation with high-resolution MR imaging at 3T. Atherosclerosis. 2009;204:447–452. doi: 10.1016/j.atherosclerosis.2008.10.019.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Kim YJ,
    2. Lee DH,
    3. Kwon JY,
    4. Kang DW,
    5. Suh DC,
    6. Kim JS,
    7. et al
    . High resolution MRI difference between moyamoya disease and intracranial atherosclerosis. Eur J Neurol. 2013;20:1311–1318. doi: 10.1111/ene.12202.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Fiebach J,
    2. Brandt T,
    3. Knauth M,
    4. Jansen O
    . [MRI with fat suppression in the visualization of wall hematoma in spontaneous dissection of the internal carotid artery]. Rofo. 1999;171:290–293. doi: 10.1055/s-1999-257.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Love BB,
    2. Biller J,
    3. Jones MP,
    4. Adams HP Jr,
    5. Bruno A
    . Cigarette smoking. A risk factor for cerebral infarction in young adults. Arch Neurol. 1990;47:693–698.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kelly ME,
    2. Bell-Stephens TE,
    3. Marks MP,
    4. Do HM,
    5. Steinberg GK
    . Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis. 2006;22:109–115. doi: 10.1159/000093238.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Goyal MS,
    2. Hallemeier CL,
    3. Zipfel GJ,
    4. Rich KM,
    5. Grubb RL Jr,
    6. Chicoine MR,
    7. et al
    . Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals. Neurosurgery. 2010;67:278–285. doi: 10.1227/01.NEU.0000371977.55753.DE.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Wakai K,
    2. Tamakoshi A,
    3. Ikezaki K,
    4. Fukui M,
    5. Kawamura T,
    6. Aoki R,
    7. et al
    . Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99 (suppl 2):S1–S5.
    OpenUrlCrossRef
  23. 23.↵
    1. Kim JS,
    2. Nah HW,
    3. Park SM,
    4. Kim SK,
    5. Cho KH,
    6. Lee J,
    7. et al
    . Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43:3313–3318. doi: 10.1161/STROKEAHA.112.658500.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Kim YD,
    2. Choi HY,
    3. Cho HJ,
    4. Cha MJ,
    5. Nam CM,
    6. Han SW,
    7. et al
    . Increasing frequency and burden of cerebral artery atherosclerosis in Korean stroke patients. Yonsei Med J. 2010;51:318–325. doi: 10.3349/ymj.2010.51.3.318.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Bogousslavsky J,
    2. Van Melle G,
    3. Regli F
    . The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19:1083–1092.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Schievink WI,
    2. Mokri B,
    3. O’Fallon WM
    . Recurrent spontaneous cervical-artery dissection. N Engl J Med. 1994;330:393–397. doi: 10.1056/NEJM199402103300604.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Bachmann R,
    2. Nassenstein I,
    3. Kooijman H,
    4. Dittrich R,
    5. Kugel H,
    6. Niederstadt T,
    7. et al
    . Spontaneous acute dissection of the internal carotid artery: high-resolution magnetic resonance imaging at 3.0 tesla with a dedicated surface coil. Invest Radiol. 2006;41:105–111.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Gao PH,
    2. Yang L,
    3. Wang G,
    4. Guo L,
    5. Liu X,
    6. Zhao B
    . Symptomatic unruptured isolated middle cerebral artery dissection: clinical and magnetic resonance imaging features [published online ahead of print September 6, 2014]. Clin Neuroradiol. http://link.springer.com/article/10.1007%2Fs00062-014-0337-z. Accessed August 13, 2014
  29. 29.↵
    1. Lin CH,
    2. Jeng JS,
    3. Yip PK
    . Middle cerebral artery dissections: differences between isolated and extended dissections of internal carotid artery. J Neurol Sci. 2005;235:37–44. doi: 10.1016/j.jns.2005.03.047.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Obusez EC,
    2. Hui F,
    3. Hajj-Ali RA,
    4. Cerejo R,
    5. Calabrese LH,
    6. Hammad T,
    7. et al
    . High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol. 2014;35:1527–1532. doi: 10.3174/ajnr.A3909.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Yang WQ,
    2. Huang B,
    3. Liu XT,
    4. Liu HJ,
    5. Li PJ,
    6. Zhu WZ
    . Reproducibility of high-resolution MRI for the middle cerebral artery plaque at 3T. Eur J Radiol. 2014;83:e49–e55. doi: 10.1016/j.ejrad.2013.10.003.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Ryoo S,
    2. Cha J,
    3. Kim SJ,
    4. Choi JW,
    5. Ki CS,
    6. Kim KH,
    7. et al
    . High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke. 2014;45:2457–2460. doi: 10.1161/STROKEAHA.114.004761.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Hauenstein C,
    2. Reinhard M,
    3. Geiger J,
    4. Markl M,
    5. Hetzel A,
    6. Treszl A,
    7. et al
    . Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51:1999–2003. doi: 10.1093/rheumatology/kes153.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Fujimura M,
    2. Sonobe S,
    3. Nishijima Y,
    4. Niizuma K,
    5. Sakata H,
    6. Kure S,
    7. et al
    . Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16:65–72. doi: 10.5853/jos.2014.16.2.65.
    OpenUrlCrossRefPubMed
View Abstract

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Back to top
Previous ArticleNext Article

This Issue

Stroke
March 2015, Volume 46, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Isolated MCA Disease in Patients Without Significant Atherosclerotic Risk Factors
    Sung-Ho Ahn, Jookyung Lee, Yeon-Jung Kim, Sun U. Kwon, Deokhee Lee, Seung-Chai Jung, Dong-Wha Kang and Jong S. Kim
    Stroke. 2015;46:697-703, originally published January 27, 2015
    https://doi.org/10.1161/STROKEAHA.114.008181

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Stroke.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Isolated MCA Disease in Patients Without Significant Atherosclerotic Risk Factors
    (Your Name) has sent you a message from Stroke
    (Your Name) thought you would like to see the Stroke web site.
  • Share on Social Media
    Isolated MCA Disease in Patients Without Significant Atherosclerotic Risk Factors
    Sung-Ho Ahn, Jookyung Lee, Yeon-Jung Kim, Sun U. Kwon, Deokhee Lee, Seung-Chai Jung, Dong-Wha Kang and Jong S. Kim
    Stroke. 2015;46:697-703, originally published January 27, 2015
    https://doi.org/10.1161/STROKEAHA.114.008181
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Vascular Biology
    • Pathophysiology
  • Stroke
    • Ischemic Stroke

Stroke

  • About Stroke
  • Instructions for Authors
  • Stroke CME
  • Guidelines and Statements
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 5th Avenue
Suite 1020
Waltham, MA 02451
email: stroke@strokeahajournal.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured